5th Oct 2021 14:11
BioPharma Credit PLC - life sciences debt investment trust - Shares transfer to the Premium Segment of the London Main Market from the Specialist Fund Segment, effective from Tuesday, following approval at the company's general meeting last Thursday. In announcing the planned move last month, BioPharma Credit said trading in the Premium Segment makes the company's shares eligible for index inclusion, bringing with this greater access to capital and potentially more liquidity. BioPharm Credit also said it intends to introduce a new stock quote in sterling, with its own ticker.
Current stock price: USD0.98
Year-to-date change: down 1.5%
By Tom Waite; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
Biopharma Cred.